À retenir
In 931 adults at a US medical centre, pulse rate variability from a light-based (PPG) sensor disagreed significantly with ECG-based heart rate variability (p < 0.001 for all) and underestimated SDNN, rMSSD and pNN50 in several chronic disease groups. The sample was patients wearing one research device, so other wearables and healthy users may differ.
Study design
Article de recherche
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Many wearables and studies use light-based photoplethysmography (PPG) as a stand-in for the electrocardiogram (ECG) when estimating heart rate variability (HRV). Earlier work had suggested the two are not equivalent, so the authors tested how closely PPG pulse rate variability (PRV) matches ECG HRV beat by beat in a large, diverse clinical group.
Population et méthode
Observational agreement study of 931 adults recruited from a tertiary academic medical center in the southeastern United States. Each participant wore two Warfighter Monitor devices (Tiger Tech Solutions), one on the chest for ECG and one on the bicep for PPG. The team computed heart rate, pulse rate and three time-domain indices: SDNN, rMSSD and pNN50, from noise-filtered NN intervals and PPG pulse peaks. Pearson correlation, Bland-Altman analysis and one-way ANOVA assessed association, bias and differences across selected chronic diseases.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1PPG-PRV and ECG-HRV differed significantly for every measure tested (p < 0.001 for all), so PPG pulse variability was a poor surrogate for ECG HRV.
- 2Mean differences by condition for rMSSD were 3.04 ms (95% CI 1.33 to 4.75) in cardiovascular disease, 2.85 ms (0.52 to 5.18) in endocrine and 4.39 ms (1.39 to 7.39) in neurological conditions.
- 3For SDNN they were 8.50 ms (5.25 to 11.74) cardiovascular, 8.43 ms (3.97 to 12.90) endocrine, 11.84 ms (6.02 to 17.67) neurological and 7.23 ms (1.83 to 12.62) respiratory.
- 4For pNN50 they were 2.48% (1.67 to 3.3) cardiovascular, 2.21% (1.12 to 3.29) endocrine, 2.91% (1.25 to 4.32) neurological and 1.46% (0.15 to 2.77) respiratory.
Limites et incertitude
- 1Only one research-grade device pair was tested, so the result does not describe a particular smartwatch or ring.
- 2Participants were hospital patients with chronic disease; the abstract does not give results for healthy people or say whether the sensors were worn at rest.
- 3The abstract gives differences for selected disease groups only, not an overall agreement figure or the correlation values.
- 4Measures were time-domain only, and this reading is based on the abstract only.
Mise en perspective
Treat wearable HRV as a useful personal trend rather than a clinical-grade heart measurement, and be cautious comparing it with ECG values or other people's numbers. The paper does not say any particular device is unusable, only that pulse-based and ECG-based variability are not the same thing.
Vos données
If your watch, ring or band gives HRV, it is probably PPG-based pulse rate variability, so compare only against your own readings from the same device taken under the same conditions, such as overnight or on waking. Look at multi-week trends instead of one reading, and do not compare with a chest-strap or ECG value.
Comprendre ce type de preuve
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Introduction
Scientists and consumer products are increasingly employing light-based photoplethysmography (PPG) instead of electrocardiography (ECG) assuming it accurately quantifies heart rate variability (HRV). Recent studies, however, have demonstrated that pulse rate variability (PRV) derived from PPG is not equivalent to HRV-derived from ECG. This study investigated the agreement between PPG-PRV and ECG-HRV in a beat-to-beat analysis in 931 adults recruited from a tertiary academic medical center in the southeastern United States.
Methods
Participants wore two (chest and bicep) Warfighter Monitor™ devices (Tiger Tech Solutions, Inc.). Heart rate (HR), pulse rate (PR) and three time-domain indices for PPG-PRV and ECG-HRV were measured. ECG-derived RR and noise-filtered NN intervals were extracted to compute HR, SDNN (standard deviation of NN intervals), rMSSD (root mean square of successive differences), and pNN50 (percentage of successive NN intervals differing by >50 ms). PPG-derived pulse-wave peaks were detected to calculate corresponding PR/PRV metrics. Pearson correlation, Bland-Altman, and one-way ANOVA analyses assessed linear association, bias, and mean differences across select chronic diseases.
Results
Significant disagreement and differences were observed between ECG-HRV and PPG-PRV (p < 0.001 for all). For rMSSD: cardiovascular: 3.04 ms, 95% CI: 1.33, 4.75, endocrine : 2.85 ms, 95% CI: 0.52, 5.18, and neurological: 4.39 ms, 95% CI: 1.39, 7.39). For SDNN: cardiovascular: 8.50 ms, 95% CI: 5.25, 11.74, endocrine: 8.43 ms, 95% CI: 3.97, 12.90, neurological: 11.84 ms, 95% CI: 6.02, 17.67, and respiratory: 7.23 ms, 95% CI: 1.83, 12.62). For pNN50: cardiovascular: 2.48%, 95% CI: 1.67, 3.3, endocrine : 2.21% 95% CI: 1.12, 3.29, neurological: 2.91%, 95% CI: 1.25, 4.32, and respiratory: 1.46%, 95% CI: 0.15, 2.77).
Discussion
PPG-PRV is a poor surrogate for ECG- HRV as it significantly underestimated SDNN, rMSSD, and pNN50 across select chronic diseases. Given the widespread use of PPG-based devices and ubiquitous, incorrect assumption that PRV accurately reflects HRV, researchers, clinicians, and manufacturers must clearly distinguish between PRV and HRV in studies and product claims.
Sources et attribution
Pulse rate variability is not the same as heart rate variability: findings from a large, diverse clinical population study.
Kantrowitz AB, Ben-David K, Morris M, Wittels HL, Wishon MJ, McDonald SM, Renaghan EJ, Feigenbaum LA, Wittels SH.
Frontiers in physiology · 2025-07-30
DOI: 10.3389/fphys.2025.1630032 ↗PubMed · 40809286 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Short-term HRV was higher during slow breathing in 962 military men, injured or not
In 962 military men (median age 37.6 years), every short-term heart rate variability (HRV) measure was higher during slow breathing at six breaths a minute than during spontaneous breathing, injured or not; in fast resting breathers RMSSD rose from 15.57 to 21.89 ms. It was one session in a fixed order, so it shows an immediate effect, not lasting benefit.
European Journal of Applied Physiology
Cold-water immersion: no strength gain, briefly weaker jumps, soreness relief uncertain
Across 22 randomised trials (375 participants, mostly men), one cold-water immersion after exercise did not change maximal isometric strength (g 0.08, 95% CI −0.11 to 0.26) and was followed by weaker jumping straight afterwards (g −0.68), gone by 24–48 hours. Lower soreness and creatine kinase looked favourable but weakened in sensitivity checks, and certainty was low to very low.
PeerJ
Cold-water immersion after hard exercise: less soreness, better power, no strength gain
In a meta-analysis of 52 randomised trials, cold-water immersion after high-intensity exercise was followed 24 hours later by lower soreness (SMD −0.89), higher perceived recovery (0.66) and better muscular power (0.22), with no effect on strength. Participants could not be blinded, most were men, and many pooled results rest on few studies with high heterogeneity.
Sports Medicine
Acute:chronic workload ratio: no evidence it can reduce injury risk, authors argue
The authors argue there is no evidence for using the acute:chronic workload ratio (ACWR) in training-load management or to reduce injury risk: no study has properly estimated a causal effect, and the ratio is statistically inaccurate and ambiguous. This is a methodological critique, not a new data analysis, so it does not show that training load is unrelated to injury.
International Journal of Sports Physiology and Performance

